Voksne patienter behandlet med somatropin, efter diagnosticeret væksthormonmangel i barndommen, rapporterede mindre hyppigt om uønskede virkninger end patienter, hvis væksthormonmangel var debuteret i voksenalderen.
Adult patients treated with somatropin, following diagnosis of growth hormone deficiency in childhood, reported undesirable effects less frequently than those with adult-onset growth hormone deficiency.